Paper8242577
New bisphosphonates in the treatment of bone metastases.
Averbuch SD. Cancer, 1993. Cited by 56 papers, by iCite.
Cite this record
ConductScience Library. New bisphosphonates in the treatment of bone metastases. Papers, record 8242577. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8242577
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Neoplasms | Major topic |
| Diphosphonates | Major topic |
| Animals | |
| Bone Resorption | |
| Humans | |
| Pain |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27002787 | Multiple myeloma in the marrow: pathogenesis and treatments. | Ann N Y Acad Sci | 2016 | https://conductscience.org/library/papers/27002787 | PubMed |
| 20882136 | Preventing bone complications in advanced prostate cancer. | Curr Oncol | 2010 | https://conductscience.org/library/papers/20882136 | PubMed |
| 20204542 | Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study. | Med Oncol | 2011 | https://conductscience.org/library/papers/20204542 | PubMed |
| 19920966 | Analgesic efficacy of zoledronic acid and its effect on functional status of prostate cancer patients with metastasis. | Patient Prefer Adherence | 2008 | https://conductscience.org/library/papers/19920966 | PubMed |
| 16533765 | Kinetics of metastatic breast cancer cell trafficking in bone. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16533765 | PubMed |
| 15286715 | The farnesyl transferase inhibitor R115777 (Zarnestra) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa) and Pamidronate. | Oncogene | 2004 | https://conductscience.org/library/papers/15286715 | PubMed |
| 12856720 | MDA-MB-435 human breast carcinoma metastasis to bone. | Clin Exp Metastasis | 2003 | https://conductscience.org/library/papers/12856720 | PubMed |
| 10780514 | Bisphosphonates in the adjuvant treatment of cancer: experimental evidence and first clinical results. International Bone and Cancer Study Group (IBCG). | Br J Cancer | 2000 | https://conductscience.org/library/papers/10780514 | PubMed |
| 10776826 | Antitumour effects of bisphosphonates: first evidence and possible mechanisms. | Drugs | 2000 | https://conductscience.org/library/papers/10776826 | PubMed |
| 10211982 | Alendronate blocks metalloproteinase secretion and bone collagen I release by PC-3 ML cells in SCID mice. | Clin Exp Metastasis | 1998 | https://conductscience.org/library/papers/10211982 | PubMed |
| 9626812 | Alendronate blocks TGF-beta1 stimulated collagen 1 degradation by human prostate PC-3 ML cells. | Clin Exp Metastasis | 1998 | https://conductscience.org/library/papers/9626812 | PubMed |
| 9509293 | Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone. | Drugs Aging | 1998 | https://conductscience.org/library/papers/9509293 | PubMed |
| 9020487 | Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9020487 | PubMed |
| 8739655 | The role of bisphosphonates in the treatment of bone metastases--the U.S. experience. | Support Care Cancer | 1996 | https://conductscience.org/library/papers/8739655 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8242577
GET https://conductscience.org/api/papers/v1/8242577/authors